查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542936

全球骨整合植入物市场 - 2024-2031

Global Osseointegration Implants Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年全球骨整合植入物市场达521万美元，预估至2031年将达1,520万美元，2024-2031年预测期间复合年增长率为15.6%

骨整合植入物是一种医疗设备，可在活骨和人造植入物表面之间建立直接连接，确保稳定性和耐用性。它们最初是为牙科应用而开发的，后来扩展到骨科和义肢，以确保关节置换和肢体义肢的安全。这项技术彻底改变了植体集成，提高了舒适度、功能性和长期成功，从而改善了各个领域的结果。

市场动态：

驱动程式和限制

设备进步的提高

骨整合可以透过微米和奈米尺度的表面修饰来改善。生物活性剂可以进一步提高骨整合潜力。目前使用的药物有无机化合物、生长因子（BMP 和非 BMP）和抗再吸收药物。因此，新一代植体的研究进展旨在积极支持骨整合处理。

此外，TSIII SOI植体是牙科植体领域的突破性进展，具有前所未有的凝血能力和优异的骨整合特性。这些生物相容性的最新成就改善了整个患者体验并支持美观和功能恢復。

与植入相关的高成本

骨整合植体市场面临诸如高成本、手术程序、手术复杂性、专业培训、监管障碍以及对长期成功和潜在併发症的担忧等挑战。这些因素使得低收入和中等收入地区的患者更难获得这些技术，并阻碍了这些技术的广泛采用。

此外，监管障碍和漫长的审批流程可能会延迟创新产品的市场进入。这些因素可能会影响患者和临床医生对采用先进解决方案的信心。

细分市场分析

全球骨整合植入物市场根据产品类型、材料类型、最终用户和地区进行细分。

该产品类型细分市场的牙种植体约占骨结合植体市场份额的41.3%

植牙产品类型细分市场占比约41.3%。牙植体对于骨整合至关重要，骨整合是植体充当人造牙根的过程。随着时间的推移，周围的骨组织生长并与植入物表面融合，形成稳定的连结。这种骨整合使植体能够牢固锚定，为牙冠、牙桥或假牙提供坚实的基础。这种黏合的强度确保植体能够承受咀嚼力并保持骨骼完整性，防止牙齿脱落后骨吸收。

例如，2024 年 2 月，牙科和脊椎市场的全球生命科学领导者 ZimVie Inc 宣布在日本推出 TSX 植体。日本作为ZimVie在亚太地区最大、全球第五大的植牙市场，对ZimVie来说具有重要的战略意义。 TSX 在日本的推出使该公司能够与牙科植牙领域的优质市场领导者展开正面竞争。

市场地域占有率

预计北美在整个预测期内将占据总市场份额的 38.4% 左右

由于新产品的推出、 FDA 的批准以及与其他公司的扩张，北美在整个预测期内预计将占据约 38.4% 的总市场份额。此外，成长可归因于发达的医疗基础设施、医疗保健支出的增加以及对微创手术的更高认识。

例如，2023 年 3 月，西维吉尼亚大学医学中心成为该国首批提供 Integrum Osseo 截肢者復健锚定义肢 (OPRA(TM)) 植入系统用于治疗下肢截肢的医疗中心之一。

此外，2023 年 7 月，Parkview 地区医疗中心和东北骨科在印第安纳州启动了一项骨整合计划，利用 Integrum 的 OPRA 植体系统。这项创新计画是该州首创，采用先进的骨锚式义肢技术来改善下肢截肢患者的生活品质。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 设备进步的提高
      • 骨科疾病盛行率上升
    • 限制
      • 与植入相关的高成本
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 专利分析
  • 大环境分析
  • SWOT分析
  • DMI 意见

第 6 章：依产品类型

  • 植牙
  • 膝关节植入物
  • 髋关节植入物
  • 脊椎植入物
  • 其他的

第 7 章：依材料类型

  • 钛植入物
  • 氧化锆植体
  • 不銹钢植入物
  • 陶瓷植入物
  • 其他的

第 8 章：最终用户

  • 医院
  • 门诊手术中心
  • 牙医诊所
  • 骨科诊所
  • 其他的

第 9 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Danaher Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Camlog
  • Osstem Implant
  • Medtronic
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Smith and Nephew Plc
  • Straumann AG Group
  • Integrum SE
  • ConMed Corporation (*LIST NOT EXHAUSTIVE)

第 12 章：附录

简介目录
Product Code: MD984

Report Overview

Global Osseointegration Implants Market reached US$ 5.21 million in 2023 and is expected to reach US$ 15.20 million by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031

Osseointegration implants are medical devices that create a direct connection between living bone and an artificial implant's surface, ensuring stability and durability. Initially developed for dental applications, they have since expanded to orthopedics and prosthetics, securing joint replacements and limb prostheses. This technology has revolutionized implant integration, improving comfort, functionality, and long-term success, leading to improved outcomes in various fields.

Market Dynamics: Drivers & Restraints

Rise in advancements of devices

Osseointegration can be improved by surface modification on the micro and nanoscale. Bioactive agents can further improve the osseointegration potential. Used agents at the moment are e.g. inorganic compounds, growth factors (BMPs and non-BMPs), and antiresorptive drugs. The advancement in research on new implant generations therefore aims at actively supporting osseointegration processing.

Moreover, the TSIII SOI implant is a groundbreaking advancement in the field of dental implantology, boasting unprecedented blood coagulation capability and excellent osseointegration characteristics. These recent achievements in biocompatibility improve the entire patient experience and support aesthetic and functional restoration.

High cost associated with implants

The osseointegration implants market faces challenges such as high costs, surgical procedures, complexity of surgery, specialized training, regulatory hurdles, and concerns about long-term success and potential complications. These factors make them less accessible to patients in low- and middle-income regions and hinder the widespread adoption of these techniques.

Additionally, regulatory hurdles and lengthy approval processes can delay market entry for innovative products. These factors can affect patient and clinician confidence in adopting advanced solutions.

Market Segment Analysis

The global osseointegration implants market is segmented based on product type, material type, end-user, and region.

The dental implants from the product type segment accounted for approximately 41.3% of the osseointegration implants market share

The dental implants from the product type segment accounted for approximately 41.3%. Dental implants are vital for osseointegration, a process where the implant acts as an artificial tooth root. Over time, the surrounding bone tissue grows and integrates with the implant's surface, forming a stable connection. This osseointegration allows the implant to be firmly anchored, providing a solid foundation for dental crowns, bridges, or dentures. The strength of this bond ensures the implant can withstand chewing forces and maintain bone integrity, preventing bone resorption after tooth loss.

For instance, in February 2024, ZimVie Inc a global life sciences leader in the dental and spine markets, announced the launch of the TSX Implant in Japan. As ZimVie's largest dental implant market in APAC and the fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, and expansion with other companies. Also, growth can be attributed to developed healthcare infrastructure, greater expenditure on healthcare, and higher awareness about minimally invasive surgeries.

For instance, in March 2023, WVU Medicine became one of the first medical centers in the country to offer the Integrum Osseo anchored Prostheses for the Rehabilitation of Amputees (OPRA(TM)) Implant System for the treatment of lower extremity amputations.

Moreover, in July 2023, Parkview Regional Medical Center and Orthopedics North East launched an osseointegration program in Indiana, utilizing Integrum's OPRA Implant System. This innovative program, the first of its kind in the state, uses advanced bone-anchored prosthesis technology to improve the quality of life for individuals with lower extremity amputations.

Market Segmentation

By Product Type

  • Dental Implants
  • Knee Implants
  • Hip Implants
  • Spinal Implants
  • Others

By Material Type

  • Titanium Implants
  • Zirconia Implants
  • Stainless Steel Implants
  • Ceramic Implants
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Dental Clinics
  • Orthopedic Clinics
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Market Competitive Landscape

The major global players in the market include Danaher Corporation, Camlog, Osstem Implant, Medtronic, Stryker Corporation, Zimmer Biomet Holdings, Smith and Nephew Plc, Straumann AG Group, Integrum SE, and ConMed Corporation among others.

Key Developments

  • In September 2023, Neoss Group, a dental implant solutions pioneer, partnered with Osstell AB to introduce NeoTell, an affordable, rapid, and precise device designed to measure implant stability. NeoTell equips clinicians with the tools to assess implant stability quickly and accurately, improving patient outcomes and simplifying digital workflow.
  • In January 2023, Specialists at the Osstem's Bone Science Research Institute devoted themselves to developing ways to regenerate bone and soft tissue by applying a state-of-the-art molecular and cell biology technique to tissue response and taking a physio-chemical approach to implant and bio-implant materials.

Why Purchase the Report?

  • To visualize the global osseointegration implants market segmentation based on product type, material type, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the osseointegration implants market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in Excel and consists of key products of all the major players.

The global osseointegration implants market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

¬¬¬¬

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in advancements of devices
      • 4.1.1.2. Rise in the prevalence of orthopedic disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High cost associated with implants
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis
  • 5.6. PESTLE Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Dental Implants *
    • 6.2.1. Introduction
  • 6.3. Knee Implants
  • 6.4. Hip Implants
  • 6.5. Spinal Implants
  • 6.6. Others

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 7.2. Market Attractiveness Index, By Material Type
  • 7.3. Titanium Implants*
    • 7.3.1. Introduction
    • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.4. Zirconia Implants
  • 7.5. Stainless Steel Implants
  • 7.6. Ceramic Implants
  • 7.7. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Dental Clinics
  • 8.5. Orthopedic Clinics
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. The U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Danaher Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Camlog
  • 11.3. Osstem Implant
  • 11.4. Medtronic
  • 11.5. Stryker Corporation
  • 11.6. Zimmer Biomet Holdings
  • 11.7. Smith and Nephew Plc
  • 11.8. Straumann AG Group
  • 11.9. Integrum SE
  • 11.10. ConMed Corporation (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us